NR 566 Advanced Pharmacology Final Exam Part 2 2026/2027 – 80+ Questions & Answers: Antidepressants, Antipsychotics, Neurology & Drug Safety – Chamberlain University

This comprehensive NR 566 Advanced Pharmacology Final Exam Part 2 2026/2027 study guide contains 80+ questions and answers across 16 pages, covering psychiatric medications, neurological pharmacology, ophthalmic treatments, respiratory drugs, immunizations, and weight management medications. The document includes drug mechanisms of action, adverse effects, contraindications, clinical indications, and medication safety concepts for graduate nursing final exam preparation. The guide covers ophthalmic and respiratory pharmacology, including betaxolol, bimatoprost, cromolyn, antihistamines, ocular decongestants, allergic rhinitis treatments, intranasal corticosteroids, montelukast, and otitis externa medications. A major section examines psychiatric pharmacology, including first-generation antipsychotics, clozapine, extrapyramidal symptoms, tardive dyskinesia, neuroleptic malignant syndrome, SSRIs, SNRIs, MAOIs, tricyclic antidepressants, lithium, bipolar disorder, depression, and serotonin syndrome. Students also review neurological pharmacology, covering Parkinson's disease medications, levodopa/carbidopa, dopamine agonists, epilepsy treatments, lamotrigine, phenytoin, carbamazepine, gabapentin, pregabalin, topiramate, Alzheimer's medications, and migraine treatments. Additional sections explore immunizations and weight management, including MMR, DTaP, IPV, pneumococcal vaccines, orlistat, GLP-1 receptor agonists, phentermine/topiramate, and naltrexone/bupropion. This resource supports NR 566 final exam revision, advanced pharmacology assessments, medication safety review, drug interaction analysis, and nurse practitioner examination preparation. Academic References 1. Rosenthal, L. D., & Burchum, J. R. Lehne's Pharmacotherapeutics for Advanced Practice Nurses and Physician Assistants. Elsevier. 2. Katzung, B. G., & Vanderah, T. W. (2021). Basic & Clinical Pharmacology (15th ed.). McGraw-Hill Education. 3. American Psychiatric Association. (2020). The American Psychiatric Association Practice Guideline for the Treatment of Patients With Schizophrenia (3rd ed.). 4. CDC. Recommended Child and Adolescent Immunization Schedule. Relevant Students Suitable for Chamberlain University NR 566 students, Master of Science in Nursing (MSN) students, Doctor of Nursing Practice (DNP) students, Family Nurse Practitioner (FNP) students, Psychiatric-Mental Health Nurse Practitioner (PMHNP) students, Adult-Gerontology Nurse Practitioner (AGNP) students, and Advanced Practice Registered Nurse (APRN) students. Especially useful for NR 566 final examinations, graduate nursing pharmacology assessments, psychiatric and neurological pharmacotherapy revision, and nurse practitioner coursework. Keywords NR 566 Final Exam 2026, NR 566 Final Exam 2027, NR 566 advanced pharmacology, NR 566 final exam part 2, NR 566 questions and answers, Chamberlain NR 566, NR 566 study guide, NR 566 practice questions, advanced pharmacology final exam, MSN pharmacology, FNP pharmacology, PMHNP pharmacology, nurse practitioner exam preparation, ophthalmic pharmacology, betaxolol, bimatoprost, cromolyn, ocular antihistamines, ocular decongestants, allergic rhinitis, intranasal corticosteroids, montelukast, otitis externa treatment, ciprofloxacin dexamethasone, ofloxacin otic, psychiatric pharmacology, first generation antipsychotics, clozapine, tardive dyskinesia, neuroleptic malignant syndrome, serotonin syndrome, SSRIs, SNRIs, MAOIs, tricyclic antidepressants, lithium therapy, bipolar disorder treatment, depression pharmacology, neurological pharmacology, Parkinson disease treatment, levodopa carbidopa, dopamine agonists, epilepsy medications, lamotrigine, phenytoin, carbamazepine, gabapentin, pregabalin, topiramate, Alzheimer disease medications, cholinesterase inhibitors, migraine treatment, triptans, MMR vaccine, DTaP vaccine, IPV vaccine, pneumococcal vaccine, orlistat, GLP 1 receptor agonists, phentermine topiramate, naltrexone bupropion, medication safety, drug contraindications, NR 566 final exam review